| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 3198255 | Journal of Allergy and Clinical Immunology | 2013 | 11 Pages |
Abstract
These data indicate that EP4 agonists as anti-inflammatory agents represent a potential therapy for diseases with increased vascular permeability and neutrophil extravasation.
Keywords
PI3KHCAECF-actinHPAECHMVEC-LpKaECISPKCS1Pfilamentous actincAMPCyclic adenosine monophosphateAcute lung injurySphingosine-1-phosphateChronic obstructive pulmonary diseasehuman pulmonary artery endothelial cellHuman coronary artery endothelial cellphosphoinositide 3-kinaseEndothelial barrierVascular leakageprotein kinase AProtein kinase CProstaglandinsprostaglandin
Related Topics
Life Sciences
Immunology and Microbiology
Immunology
Authors
Viktoria PhD, Andreas PhD, Nora BSc, Anna BSc, Sonia PhD, Gerald P. BSc, Gunther PhD, Bernhard A. MD, Rufina PhD, Wolfgang PhD, Akos MD,